The years of declining R&D productivity will be a thing of the past according to The Tufts Center for the Study of Drug Development Outlook 2006 report on drug and biotech development trends. “Key to improving R&D productivity is the willingness of drug developers to use new discovery tools, such as pharmacogenomics, to accelerate the pace of translating basic research into viable drug candidates, and the aggressive management of clinical trials, through advanced data analysis and ...